Predictive Oncology (POAI) Competitors $1.10 +0.03 (+2.80%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$1.07 -0.03 (-2.64%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. POCI, DRIO, MDAI, PYPD, COCH, CLGN, NMTC, NXL, NEPH, and RVPShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include Precision Optics (POCI), DarioHealth (DRIO), Spectral AI (MDAI), PolyPid (PYPD), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), NeuroOne Medical Technologies (NMTC), Nexalin Technology (NXL), Nephros (NEPH), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. Precision Optics DarioHealth Spectral AI PolyPid Envoy Medical CollPlant Biotechnologies NeuroOne Medical Technologies Nexalin Technology Nephros Retractable Technologies Precision Optics (NASDAQ:POCI) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends. Does the MarketBeat Community believe in POCI or POAI? Predictive Oncology received 149 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 64.22% of users gave Predictive Oncology an outperform vote while only 0.00% of users gave Precision Optics an outperform vote. CompanyUnderperformOutperformPrecision OpticsOutperform VotesNo VotesUnderperform Votes2100.00% Predictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% Do insiders & institutionals believe in POCI or POAI? 13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by company insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is POCI or POAI more profitable? Precision Optics has a net margin of -21.46% compared to Predictive Oncology's net margin of -1,012.32%. Precision Optics' return on equity of -39.17% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Precision Optics-21.46% -39.17% -22.93% Predictive Oncology -1,012.32%-286.30%-122.11% Which has preferable valuation and earnings, POCI or POAI? Precision Optics has higher revenue and earnings than Predictive Oncology. Precision Optics is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecision Optics$18.68M1.82-$2.95M-$0.64-6.94Predictive Oncology$1.62M6.05-$13.98M-$3.05-0.36 Does the media refer more to POCI or POAI? In the previous week, Predictive Oncology had 2 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for Predictive Oncology and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.87 beat Predictive Oncology's score of 0.96 indicating that Precision Optics is being referred to more favorably in the media. Company Overall Sentiment Precision Optics Very Positive Predictive Oncology Positive Which has more risk & volatility, POCI or POAI? Precision Optics has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Do analysts rate POCI or POAI? Predictive Oncology has a consensus target price of $3.00, suggesting a potential upside of 172.73%. Given Predictive Oncology's stronger consensus rating and higher possible upside, analysts plainly believe Predictive Oncology is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryPrecision Optics beats Predictive Oncology on 9 of the 17 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologySurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.83M$9.15B$5.56B$7.83BDividend YieldN/A1.64%5.11%4.22%P/E Ratio-0.3619.2722.4818.48Price / Sales6.0571.13395.93103.60Price / CashN/A19.6738.1834.62Price / Book0.544.956.774.25Net Income-$13.98M$284.66M$3.22B$248.23M7 Day Performance0.92%0.01%1.47%0.89%1 Month Performance-25.68%1.87%3.99%3.53%1 Year Performance-33.33%-17.14%16.15%5.08% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology2.7967 of 5 stars$1.10+2.8%$3.00+172.7%-23.1%$9.83M$1.62M-0.3630POCIPrecision Optics0.6287 of 5 stars$3.99+1.0%N/A-20.7%$30.59M$18.68M-6.2380Positive NewsGap UpDRIODarioHealth2.0804 of 5 stars$0.73-2.7%$1.50+105.5%-49.6%$30.34M$27.04M-0.78200MDAISpectral AI2.9815 of 5 stars$1.18-4.8%$4.75+302.5%-27.0%$29.87M$29.58M-1.8283Upcoming EarningsShort Interest ↓News CoverageGap DownPYPDPolyPid2.1396 of 5 stars$2.75+0.4%$11.33+312.1%-40.3%$28.03MN/A-0.5580Upcoming EarningsShort Interest ↑News CoverageGap UpCOCHEnvoy Medical2.3628 of 5 stars$1.31-2.2%$9.13+596.6%-66.6%$27.94M$225,000.00-0.9334Gap UpCLGNCollPlant Biotechnologies2.398 of 5 stars$2.35-2.9%$12.50+431.9%-63.9%$26.92M$515,000.00-1.5370Short Interest ↑NMTCNeuroOne Medical Technologies0.5183 of 5 stars$0.57-2.2%N/A-44.8%$26.87M$5.75M-2.1820Short Interest ↑NXLNexalin Technology2.4922 of 5 stars$1.73+2.7%$5.00+188.4%+19.0%$23.07M$168,721.00-2.713Gap UpNEPHNephros2.396 of 5 stars$1.97-1.5%$5.00+153.8%-11.9%$20.88M$14.16M-21.8930Upcoming EarningsShort Interest ↓News CoverageRVPRetractable TechnologiesN/A$0.69-1.1%N/A-31.8%$20.66M$33.05M-1.28240Analyst Forecast Related Companies and Tools Related Companies Precision Optics Competitors DarioHealth Competitors Spectral AI Competitors PolyPid Competitors Envoy Medical Competitors CollPlant Biotechnologies Competitors NeuroOne Medical Technologies Competitors Nexalin Technology Competitors Nephros Competitors Retractable Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy POAI Stock Free POAI Stock Alerts